Azitra (AZTR) Current Leases (2022 - 2026)
Azitra's (AZTR) quarterly Current Leases came in at $5850.0 in Q1 2026, down 97.54% YoY from $237647.0 in Q1 2025, and down 97.71% on a QoQ basis from $255776.0 in Q4 2025.
Azitra (AZTR) Current Leases (2022 - 2026) Analysis & Trends
Azitra (AZTR) has 5 years of Current Leases data on file, last reported at $5850.0 in Q1 2026.
- Quarterly Current Leases fell 97.54% year-over-year to $5850.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5850.0 (down 97.54% YoY) and the FY2025 annual result came in at $255776.0, up 1492.03% from the prior year.
- Current Leases slipped to $5850.0 in Q1 2026, from $255776.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $298047.0 in Q2 2023 to a low of $5850.0 in Q1 2026.
- A 5-year average of $92823.6 and a median of $15687.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2025 — Current Leases surged 1492.03% — and 2026, when it tumbled 97.54%.
- Tracing AZTR's Current Leases over 5 years: stood at $287384.0 in 2022, then tumbled by 94.92% to $14600.0 in 2023, then rose by 10.04% to $16066.0 in 2024, then surged by 1492.03% to $255776.0 in 2025, then slumped by 97.71% to $5850.0 in 2026.
- The last three Current Leases figures came in at $5850.0 (Q1 2026), $255776.0 (Q4 2025), and $14271.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Azitra | 2.44 Mn | 2.44 Mn | - | 357,569.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 357,569.00 |
| Mar 31, 2026 | 5,850.00 |
| Dec 31, 2025 | 255,776.00 |
| Sep 30, 2025 | 14,271.00 |
| Jun 30, 2025 | 16,854.00 |
| Mar 31, 2025 | 237,647.00 |
| Dec 31, 2024 | 16,066.00 |
| Sep 30, 2024 | 15,687.00 |
| Jun 30, 2024 | 15,317.00 |
| Mar 31, 2024 | 14,954.00 |
| Dec 31, 2023 | 14,600.00 |
| Sep 30, 2023 | 14,254.00 |
| Jun 30, 2023 | 298,047.00 |
| Dec 31, 2022 | 287,384.00 |